Molecure has obtained confirmation of scientific assumptions (PoC) in the development of its mRNA platform biznespolska.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznespolska.pl Daily Mail and Mail on Sunday newspapers.
Molecure may sign 2-3 partnership agreements by 2025 biznespolska.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznespolska.pl Daily Mail and Mail on Sunday newspapers.
Our new name "Molecure" reflects expansion of scope of small molecule targets from novel proteins to mRNA in discovery & development of breakthrough therapies.
Medical biotech in Poland is having a Goldilocks moment. Its companies are hot enough to drive a significant local ecosystem, but not so numerous that competition for public cash or talent is cut-throat. Yet there is also room for improvement, with the coverage and management of public funding seen as flawed, smart private investment scarce, academic researchers often out of synch with commercial needs and a shortage of the clinical development and regulatory skills that are needed to take drugs through to the market.